相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proton pump inhibitors reduce breast cancer risk in gastric ulcer patients: A population-based cohort study
Dah-Ching Ding et al.
BREAST JOURNAL (2020)
Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C
Wei-Yu Kao et al.
HEPATOLOGY (2019)
Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study
Chao-Hung Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Alcohol, liver disease and the gut microbiota
Jasmohan S. Bajaj
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study
Oskar O. E. Halfdanarson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis
Ryota Niikura et al.
GUT (2018)
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
Ka Shing Cheung et al.
GUT (2018)
Association between proton pump inhibitors and the risk of hepatocellular carcinoma
Y. -H. J. Shao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies
K. T. Tran et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans
M. C. Tan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis
Md. Mohaimenul Islam et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Acid-suppressive drugs and risk of kidney disease: A systematic review and meta-analysis
Tingting Qiu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Use of proton pump inhibitors and risk of pancreatic cancer
Blanaid Hicks et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
Yen-Chun Peng et al.
FRONTIERS IN PHARMACOLOGY (2018)
Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
In Cheol Hwang et al.
PLOS ONE (2018)
Letter: proton pump inhibitors use and risk of hepatocellular carcinoma: A meta-analysis of observational studies
Jian Zhao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study
Yen-Chun Peng et al.
DOSE-RESPONSE (2018)
Alteration of Gut Microbiome in Lung Cancer Patients
M. Li et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES
D. K. Li et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Medication use and kidney cancer risk: A population-based study
Madhur Nayan et al.
EUROPEAN JOURNAL OF CANCER (2017)
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
Anca Trifan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus
Cristina Llorente et al.
NATURE COMMUNICATIONS (2017)
Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis
Qiang Hu et al.
PLOS ONE (2017)
Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
In Cheol Hwang et al.
PLOS ONE (2017)
Gastrin and Gastric Cancer
Jill P. Smith et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Proton pump inhibitors on pancreatic cancer risk and survival
Malcolm D. Kearns et al.
CANCER EPIDEMIOLOGY (2017)
Proton pump inhibitors and risk of periampullary cancers-A nested case-control study
Li-Nien Chien et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis
An Tran-Duy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Hypergastrinemia
Sunil Dacha et al.
GASTROENTEROLOGY REPORT (2015)
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert et al.
PLOS ONE (2015)
The Gut Microbiota and Liver Disease
Cristina Llorente et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Changes in Gastric and Lung Microflora With Acid Suppression Acid Suppression and Bacterial Growth
Rachel Rosen et al.
JAMA PEDIATRICS (2014)
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Philip O. Katz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity
Soo Young Kim et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients - an exploratory analysis
Chia-Lin Hsu et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications
David A. Kleiman et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2013)
Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies
Jeong Soo Ahn et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study
M. C. Bradley et al.
BRITISH JOURNAL OF CANCER (2012)
Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action
Hitomi Hayashi et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2012)
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
A. H. Poulsen et al.
BRITISH JOURNAL OF CANCER (2009)
Antacid Drug Use and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County
Lei Duan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Colorectal cancer risk in relation to use of acid suppressive medications
Jessica Chubak et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Proton pump inhibitors and the risk of colorectal cancer
Eva M. van Soest et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationship between Histamine(2)-receptor antagonist medications and risk of invasive breast cancer
Robert W. Mathes et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Association between use of acid-suppressive drugs and risk of gastric cancer - A nested case-control study
Hani Tamim et al.
DRUG SAFETY (2008)
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
Yu-Xiao Yang et al.
GASTROENTEROLOGY (2007)
Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
Douglas J. Robertson et al.
GASTROENTEROLOGY (2007)
Cimetidine use and the risk for prostate cancer: Results from the VITAL cohort study
Christine M. Velicer et al.
ANNALS OF EPIDEMIOLOGY (2006)
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy
M. Jalving et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use
PD Siersema et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholanglocytes via oxidative DNA damage
D Komichi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer
PF Coogan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma
AB Beiderbeck et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Gastric polyps and nodules in children receiving long-term omeprazole therapy
DS Pashankar et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Long term omeprazole therapy for reflux esophagitis: follow-up in serum gastrin levels, EC cell hyperplasia and neoplasia
P Singh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2000)
H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study
UL Suleiman et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2000)
An age, period and cohort analysis of pleural cancer mortality in Europe
C La Vecchia et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2000)
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment
A Cats et al.
HUMAN PATHOLOGY (2000)
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
DC Farrow et al.
CANCER CAUSES & CONTROL (2000)
分享论文
